112 related articles for article (PubMed ID: 17968328)
1. Hematopoietic stem cell transplantation for primary immunodeficiency disease.
Dvorak CC; Cowan MJ
Bone Marrow Transplant; 2008 Jan; 41(2):119-26. PubMed ID: 17968328
[TBL] [Abstract][Full Text] [Related]
2. Severe combined immunodeficiency diagnosis and genetic defects.
Aranda CS; Gouveia-Pereira MP; da Silva CJM; Rizzo MCFV; Ishizuka E; de Oliveira EB; Condino-Neto A
Immunol Rev; 2024 Mar; 322(1):138-147. PubMed ID: 38287514
[TBL] [Abstract][Full Text] [Related]
3. Impact of Genetic Diagnosis on the Outcome of Hematopoietic Stem Cell Transplant in Primary Immunodeficiency Disorders.
Forlanini F; Chan A; Dara J; Dvorak CC; Cowan MJ; Puck JM; Dorsey MJ
J Clin Immunol; 2023 Apr; 43(3):636-646. PubMed ID: 36495401
[TBL] [Abstract][Full Text] [Related]
4. Global and Local Manipulation of DNA Repair Mechanisms to Alter Site-Specific Gene Editing Outcomes in Hematopoietic Stem Cells.
Benitez EK; Lomova Kaufman A; Cervantes L; Clark DN; Ayoub PG; Senadheera S; Osborne K; Sanchez JM; Crisostomo RV; Wang X; Reuven N; Shaul Y; Hollis RP; Romero Z; Kohn DB
Front Genome Ed; 2020; 2():601541. PubMed ID: 34713224
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.
Mamcarz E; Zhou S; Lockey T; Abdelsamed H; Cross SJ; Kang G; Ma Z; Condori J; Dowdy J; Triplett B; Li C; Maron G; Aldave Becerra JC; Church JA; Dokmeci E; Love JT; da Matta Ain AC; van der Watt H; Tang X; Janssen W; Ryu BY; De Ravin SS; Weiss MJ; Youngblood B; Long-Boyle JR; Gottschalk S; Meagher MM; Malech HL; Puck JM; Cowan MJ; Sorrentino BP
N Engl J Med; 2019 Apr; 380(16):1525-1534. PubMed ID: 30995372
[TBL] [Abstract][Full Text] [Related]
6. The TLR7 ligand R848 prevents mouse graft-
Gaignage M; Marillier RG; Cochez PM; Dumoutier L; Uyttenhove C; Coutelier JP; Van Snick J
Haematologica; 2019 Feb; 104(2):392-402. PubMed ID: 30213828
[TBL] [Abstract][Full Text] [Related]
7. TALEN-mediated functional correction of human iPSC-derived macrophages in context of hereditary pulmonary alveolar proteinosis.
Kuhn A; Ackermann M; Mussolino C; Cathomen T; Lachmann N; Moritz T
Sci Rep; 2017 Nov; 7(1):15195. PubMed ID: 29123113
[TBL] [Abstract][Full Text] [Related]
8. TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host Disease.
Lee YK; Kang M; Choi EY
Immune Netw; 2017 Jun; 17(3):144-151. PubMed ID: 28680375
[TBL] [Abstract][Full Text] [Related]
9. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.
Dietz AC; Savage SA; Vlachos A; Mehta PA; Bresters D; Tolar J; Bonfim C; Dalle JH; de la Fuente J; Skinner R; Boulad F; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1422-1428. PubMed ID: 28533057
[TBL] [Abstract][Full Text] [Related]
10. In vivo engineering of bone tissues with hematopoietic functions and mixed chimerism.
Shih YR; Kang H; Rao V; Chiu YJ; Kwon SK; Varghese S
Proc Natl Acad Sci U S A; 2017 May; 114(21):5419-5424. PubMed ID: 28484009
[TBL] [Abstract][Full Text] [Related]
11. The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies.
Dietz AC; Duncan CN; Alter BP; Bresters D; Cowan MJ; Notarangelo L; Rosenberg PS; Shenoy S; Skinner R; Walters MC; Wagner J; Baker KS; Pulsipher MA
Biol Blood Marrow Transplant; 2017 Jan; 23(1):24-29. PubMed ID: 27737772
[TBL] [Abstract][Full Text] [Related]
12. T-cell abnormalities in common variable immunodeficiency: the hidden defect.
Wong GK; Huissoon AP
J Clin Pathol; 2016 Aug; 69(8):672-6. PubMed ID: 27153873
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders.
Mahmoud HK; Elhaddad AM; Fahmy OA; Samra MA; Abdelfattah RM; El-Nahass YH; Fathy GM; Abdelhady MS
J Adv Res; 2015 May; 6(3):449-58. PubMed ID: 26257943
[TBL] [Abstract][Full Text] [Related]
14. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.
Dvorak CC; Hassan A; Slatter MA; Hönig M; Lankester AC; Buckley RH; Pulsipher MA; Davis JH; Güngör T; Gabriel M; Bleesing JH; Bunin N; Sedlacek P; Connelly JA; Crawford DF; Notarangelo LD; Pai SY; Hassid J; Veys P; Gennery AR; Cowan MJ
J Allergy Clin Immunol; 2014 Oct; 134(4):935-943.e15. PubMed ID: 25109802
[TBL] [Abstract][Full Text] [Related]
15. Cord blood transplantation is associated with rapid B-cell neogenesis compared with BM transplantation.
Nakatani K; Imai K; Shigeno M; Sato H; Tezuka M; Okawa T; Mitsuiki N; Isoda T; Tomizawa D; Takagi M; Nagasawa M; Kajiwara M; Yamamoto M; Arai A; Miura O; Kamae C; Nakagawa N; Honma K; Nonoyama S; Mizutani S; Morio T
Bone Marrow Transplant; 2014 Sep; 49(9):1155-61. PubMed ID: 24978139
[TBL] [Abstract][Full Text] [Related]
16. A trial of alemtuzumab adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency.
Dvorak CC; Horn BN; Puck JM; Adams S; Veys P; Czechowicz A; Cowan MJ
Pediatr Transplant; 2014 Sep; 18(6):609-16. PubMed ID: 24977928
[TBL] [Abstract][Full Text] [Related]
17. A trial of plerixafor adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency.
Dvorak CC; Horn BN; Puck JM; Czechowicz A; Shizuru JA; Ko RM; Cowan MJ
Pediatr Transplant; 2014 Sep; 18(6):602-8. PubMed ID: 24977650
[TBL] [Abstract][Full Text] [Related]
18. Distribution and clonality of the vα and vβ T-cell receptor repertoire of regulatory T cells in leukemia patients with and without graft versus host disease.
Jin Z; Wu X; Chen S; Yang L; Liu Q; Li Y
DNA Cell Biol; 2014 Mar; 33(3):182-8. PubMed ID: 24410134
[TBL] [Abstract][Full Text] [Related]
19. Use of V(D)J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies.
Serana F; Chiarini M; Zanotti C; Sottini A; Bertoli D; Bosio A; Caimi L; Imberti L
J Transl Med; 2013 May; 11():119. PubMed ID: 23656963
[TBL] [Abstract][Full Text] [Related]
20. Stem cell transplantation for primary immunodeficiency disease: experience of a singapore hospital.
Lee AJ; Wu J; Villegas MS; Shek LP; Lee BW; Tan PL
World Allergy Organ J; 2012 Mar; 5(3):41-4. PubMed ID: 23268471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
